|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���Ʒ� |
|
�⻯ѧ�Ʒ� |
|
�����֯���� |
| ��������������� | |
|
���� |
|
�Ÿ��� |
| PubMed | |
|
Article by |
|
Article by |
���Ƽ��⻯ѧ�Ʒ����ƽ����֯����չ
����, �Ÿ���
ɽ��ʡƤ�����Բ������о��� ���� 250022
���Ƽ��⻯ѧ�Ʒ���ijЩƤ�����ж��ص���Ч,�����ƾ�����ӲƤ����ϵͳ��Ӳ��֢������ֳ����λӲ��ή����̦��ϵͳ�Ժ���Ǵ�������ϸ�������Խ�Ĥ�ס��²���ȫӲ����Ӳ�߲���Ӳ�����Һˮ�ס�����Ӳ�ײ���PDEMS�ۺ����Ƚ����֯��,ȡ���������������Ч��
[2] El-Mofty M, Mostafa W, Esmat S, et al. Suggested mechanisms of action of UVA phototherapy in morphea:a molecular study. Photodermatol Photoimmunol Photomed, 2004, 20:93-100.
[3] El-Mofty M, Mostafa W, El-Darouty M, et al. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. Photodermatol Photoimmunol Photomed, 2004, 20:148-156.
[4] de Rie MA, Enomoto DN, de Vries HJ, et al. Evaluation of mediumdose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology, 2003, 207:298.
[5] Grundmann-Kollmann M, Ochsendorf F, Zollner TM, et al. PUVA cream photochemotherapy for the treatment of localized scleroderma. J Am Acad Dermatol, 2000, 43:675-678.
[6] Yin L, Yamauchi R, Tsuji T, et al. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400 nm) isphototherapy relevant to the glutathione (GSH) content in skin fi broblasts of systemic sclerosis. J Dermatol, 2003, 30:173-180.
[7] Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis:effects on acrosclerosis. J Am Acad Dermatol, 2004, 50:740-747.
[8] Morita A, Kobayashi K, Isomura I, et al. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol, 2000, 43:670-674.
[9] Breuckmann F, Stuecker M, Altmeyer P, et al. Modulation of en dothelial dysfunction and apoptosis:UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res, 2004, 296:235.
[10] Breuckmann F, Appelhans C, Bastian A, et al. UVA1-induced decrease in dermal neuron-specific enolase (NSE) in acrosclerosis. Arch Dermatol Res, 2004, 296:182-184.
[11] Hofer A, Soyer HP. Oral psoralen-UV-A for systemic scleroderma. Arch Dermatol, 1999, 135:603-604.
[12] Kreuter A, Jansen T, Stucker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol, 2001, 26:30-32.
[13] Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus:results of a preliminary study. J Am Acad Dermatol, 2002, 46:251-255.
[14] Reichrath J, Reinhold U, Tilgen W. Treatment of genito-anal lesions in inflammatory skin diseases with PUVA cream photochemotherapy:an open pilot study in 12 patients. Dermatology, 2002, 205:245-248.
[15] Polderman MC, Huizinga TW, Le Cessie S, et al. UVA-1 cold light treatment of SLE:a double blind, placebo controlled crossover trial. Ann Rheum Dis, 2001, 60:112-115.
[16] Polderman MC, le Cessie S, Huizinga TW, et al. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology (Oxford), 2004, 43:1402-1404.
[17] Breuckmann F, Avermaete A, Kreuter A, et al. Indications for UVA1 phototherapy:An Update. Photodermatol Photoimmunol Photomed, 2001, 17:83.
[18] Schiener R, Behrens-Williams SC, Gottlober P, et al. Eosinophilic fasciitis treated with psoralen-ultraviolet A bath photochemotherapy.Br J Dermatol, 2000, 142:804-807.
[19] Yildirim M, Baysal V, Aridogan BC, et al. Pansclerotic morphea treated with UVA:a case report. J Dermatol, 2003, 30:625-627.
[20] Scharffetter-Kochanek K, Goldermann R, Lehmann P, et al. PUVA therapy in disabling pansclerotic morphoea of children. Br J Dermatol, 1995, 132:830-831.
[21] Adachi Y, Iba S, Horio T. Successful treatment of lichen myxoedematosus with PUVA photochemotherapy. hotodermatol Photoimmunol Photomed, 2000, 6:229-231.
[22] rundmann-Kollmann M, Ochsendorf F, Zollner TM, et al. Cream PUVA therapy for scleredema adultorum. Br J Dermatol, 2000, 142:1058.
[23] Schaller M, Romiti R, Wollenberg A, et al. Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol, 2001, 45:969-970.